Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Janssen gets FDA approval for Invokana to reduce risk of CV events

pharmaceutical-technologyNovember 01, 2018

Tag: Janssen , FDA , INVOKANA , CV

PharmaSources Customer Service